Pancreatic cancer pill shows major breakthrough in early trials
Summarised from 4 outlets · Updated 20 Nov, 09:45 · Archive
A daily pill called daraxonrasib shrank or eliminated tumours in patients with advanced pancreatic cancer when combined with chemotherapy.
A daily pill called daraxonrasib has produced results described as the biggest breakthrough in pancreatic cancer treatment for decades. In early clinical trials, cancer became undetectable on scans in one in twelve patients given the drug combined with chemotherapy. Tumours stopped growing in almost all of the 61 participants who had recently been diagnosed with advanced pancreatic cancer that had spread to other parts of the body. About 61 per cent of patients saw their tumours shrink or disappear entirely.
Pancreatic cancer is notoriously difficult to treat and has the lowest survival rate of all common cancers in the UK. Advanced disease typically leads to survival measured in months rather than years, though standard chemotherapy can achieve modest tumour shrinkage. One year after treatment with daraxonrasib and chemotherapy, 76.6 per cent of patients were still alive, compared with around 40 to 45 per cent when given chemotherapy alone.
The drug works by targeting the mutated KRAS gene, which is found in more than nine in ten pancreatic tumours and drives cancer cell growth. By blocking this gene, daraxonrasib prevents tumours from spreading. Doctors stress that the pill cannot yet be considered a cure and that it remains unclear how long it might keep the disease at bay. Cancer Research UK called the results "the biggest leap forward in decades" for pancreatic cancer patients.
The trial followed participants for an average of eighteen months. Some patients did not see their cancer return during this period, though longer studies are needed to establish whether any patients can achieve full remission. Doctors hope the treatment will offer patients more time, even if it cannot eliminate cancers permanently. The pill also caused fewer side effects than standard treatment, experts said.

How it is being reported
- 'Biggest leap forward in decades': Daily pill makes deadly cancer tumours disappear in major trialA once-daily tablet called daraxonrasib has produced remarkable results in an early clinical trial when administered alongside chemotherapy. Trials have shown it rendering tumours undetectable in roughly one in 12 patients with advanced pancreatic cancer. The findings, unveiled at a European cancer research conference in Barcelona, have been hailed by Cancer Research UK as "the biggest leap forward we've seen in decades" for those facing one of the most lethal and treatment-resistant forms of the disease. Michelle Mitchell, the charity's chief executive, said the drug "could offer real hope…GB News · 20 Nov, 09:51
- Major breakthrough after pill wipes out deadliest cancer in patientsA new pill is ‘closest thing to a cure’ for pancreatic cancer (Picture: Alamy Stock Photo) A new once-a-day pill has wiped out pancreatic cancer in some patients in a huge breakthrough for treatment. One in 12 patients had their advanced pancreatic cancer completely eradicated using the drug…Metro · 20 Nov, 09:37
- Pill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’Cancer undetectable for one in 12 patients in daraxonrasib trial, while nearly all participants’ tumours stopped growing A pill that can shrink and potentially eliminate pancreas tumours is being hailed as the biggest breakthrough treatment for the cancer in decades. In one in 12 of the patients given the drug, daraxonrasib, during a trial, the cancer became undetectable, and the tumours stopped growing in almost all of the 61 patients. The trial participants had recently been diagnosed with advanced pancreatic cancer that had spread to other parts of the body. Continue reading...The Guardian · 20 Nov, 09:36
- Massive hope for pancreatic cancer pill after trial saw tumours vanishDaily pill daraxonrasib appears to shrink and possibly even eliminate tumours in some patients with one of the deadliest cancers.BBC News · 20 Nov, 00:08
In this story: daraxonrasib · Cancer Research UK · UK
This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log
Comments (0)